Malaysian Genomics Resource Centre Berhad's latest marketcap:
As of 08/06/2025, Malaysian Genomics Resource Centre Berhad's market capitalization has reached $6.49 M. According to our data, Malaysian Genomics Resource Centre Berhad is the 42973th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 6.49 M |
| Revenue (ttm) | 1.21 M |
| Net Income (ttm) | -835,436.95 |
| Shares Out | 137.21 M |
| EPS (ttm) | -0.01 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 01/09/2020 |
| Earnings Date | 08/20/2025 |
Malaysian Genomics Resource Centre Berhad's yearly market capitalization.
| Date | Market Cap(RM) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/06/2025 | RM27.44 M | $6.49 M | -43.48% | 42973 |
| 12/31/2024 | RM47.34 M | $10.56 M | -22.47% | 37736 |
| 12/29/2023 | RM61.06 M | $13.27 M | -38.7% | 35835 |
| 12/30/2022 | RM99.61 M | $22.57 M | -30.87% | 31959 |
| 12/31/2021 | RM144.08 M | $34.51 M | 36.47% | 29818 |
| 12/31/2020 | RM105.58 M | $26.19 M | 151.85% | 28210 |
| 12/31/2019 | RM41.92 M | $10.22 M | 72.34% | 28796 |
| 12/10/2018 | RM24.32 M | $5.87 M | -32.86% | 29349 |
| 12/29/2017 | RM36.23 M | $8.93 M | -36.36% | 27918 |
| 12/29/2016 | RM56.93 M | $12.66 M | -19.33% | 24688 |
Company Profile
About Malaysian Genomics Resource Centre Berhad
Malaysian Genomics Resource Centre Berhad is an investment holding company specializing in genetics, genomics, immunotherapy, and biopharmaceutical services on a global scale.
Core Services
- Genome Sequencing: Offers comprehensive sequencing for humans, animals, plants, and microbes, including whole genome, transcriptome, metagenomics, and metatranscriptomics services.
- Genome Analysis: Provides bioinformatics services such as reads quality analysis, whole genome assembly, variation analysis, gene annotation, exome and transcriptome analysis, and specialized pipelines for ChIP-Seq, microRNA, and mutation analysis.
- Trait Analysis & Trio Sequencing: Screens genetic markers in plant and animal genomes and delivers detailed DNA insights for individuals.
- Genetic Screening: Features Dtect, a suite of test panels for identifying genetic markers in DNA.
- Cancer Immunotherapy: Develops targeted treatments for various cancer types.
Additional Business Activities
- Life sciences/cell laboratory operations and byproducts.
- Distribution of beauty products and precision medicine.
- Research, development, and commercialization of biopharmaceutical products.
- Supply of healthcare products and general medical services.
- Capital market and derivative instruments trading.
Research Collaboration
Partners with Universiti Sains Malaysia to study the genetics of Penang Woman and determine the age of the ancient Penang Women Skeleton using Accelerator Mass Spectrometry (AMS) dating.
Company Background
Founded in 2004, Malaysian Genomics Resource Centre Berhad is headquartered in Petaling Jaya, Malaysia.
Frequently Asked Questions
-
What is Malaysian Genomics Resource Centre Berhad's (KLSE-MGRC) current market cap?As of 08/06/2025, Malaysian Genomics Resource Centre Berhad (including the parent company, if applicable) has an estimated market capitalization of $6.49 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Malaysian Genomics Resource Centre Berhad (KLSE-MGRC) rank globally by market cap?Malaysian Genomics Resource Centre Berhad global market capitalization ranking is approximately 42973 as of 08/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.